Brain Tunnelgenix Technologies Receives FDA Approval for Abreu BTT(TM) System for Continuous Temperature Monitoring
9/9/2010 1:08:47 PM
More...
|
U.S. Patent Office Ruled Oculir Patent Invalid Based on Dr. Marc Abreu's Technology for Diabetes Monitoring --
Brain Tunnelgenix Technologies to Launch First Noninvasive Glucose and Brain Temperature Measurement Device
8/19/2010 9:35:58 AM
More...
|
Brain Tunnelgenix Technologies Launched To Harness Discovery of Brain Temperature Tunnel(TM); Company Has Raised More Than $4 Million in Funding
6/22/2010 7:03:56 AM
More...
|